Friday, March 29, 2024 11:38 AM ET
1 day ago
Sexually transmitted infection rates have risen sharply among adults 55 and older, CDC data shows1 day ago
UnitedHealth Group has paid more than $3 billion to providers after cyberattack1 day ago
Altimmune's experimental weight loss drug minimized loss of muscle mass in trial1 day ago
Novo Nordisk's Ozempic can be made for less than $5 a month, study suggests1 day ago
Moderna moves three vaccines into final stage trials, aims to rebound from Covid slump1 day ago
FDA approves Merck's drug for rare, deadly lung condition2 days ago
Healthy Returns: Drugmakers cap inhaler prices at $35 in win for some patients2 days ago
Moderna says new Covid vaccine showed positive late-stage data2 days ago
Supreme Court signals it is likely to reject a challenge to abortion pill access2 days ago
Viking Therapeutics stock jumps more than 15% on promising weight loss pill data3 days ago
Supreme Court weighs challenge to abortion pill's widespread availability3 days ago
Nvidia's AI ambitions in medicine and health care are becoming clear5 days ago
Amgen wants to enter the weight loss drug market with a new approach5 days ago
How much people are willing to spend on weight loss drugs, according to a survey5 days ago
Falling fertility rates pose major challenges for the global economy, report finds7 days ago
Medicare can now cover certain weight loss drugs in a big step for patients7 days ago
We're buying more of this health-care company amid an overdone sell-off8 days ago
Neuralink shares video of patient chess player using signals from brain implant8 days ago
FDA says safety issues with China-made syringes are 'more widespread' than previously known9 days ago
Nvidia stomps the bears. Plus, Cramer on struggling stocks Starbucks, Abbott9 days ago
Cramer defends Elon Musk's use of ketamine for depression, says the CEO saved lives9 days ago
Healthy Returns: First NASH liver disease drug is here – and more are coming10 days ago
Nvidia and Johnson & Johnson to develop new AI applications for surgery10 days ago
UnitedHealth Group paid more than $2 billion to providers following cyberattack10 days ago
Disney gets a win in Peltz board fight. 2 other portfolio stocks mount comebacks10 days ago
Elon Musk suggests his prescription ketamine use is good for investors10 days ago
Cramer: It's not too late to buy this health-care stock after Friday's selloff10 days ago
Doctors are turning medical generative AI into a booming business13 days ago
Wegovy, approved for heart health, won't get broad insurance coverage just yet11 days ago
FDA approves NASH liver disease drug from Madrigal Pharmaceuticals, shares pop13 days ago
WeightWatchers CEO sends internal memo to employees as stock crashes14 days ago
A firm that serves kids with autism grew until it had 265 clinics. Then private equity took over.15 days ago
Experts hesitate on weight loss ETFs amid the obesity drug boom15 days ago